Drug of increasing stigma exposing ratio of sterile line rice and preparing method thereof

A technology of exposed stigma and rice, which is applied in the agricultural field, can solve the problems of low stigma exposure rate, low seed setting rate, and low yield of sterile lines, so as to improve the stigma exposure rate of rice sterile lines, promote elongation, and promote cell growth Effect

Inactive Publication Date: 2008-07-23
SAAS BIOTECH & NUCLEAR TECH RES INST +1
View PDF0 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] The purpose of the present invention is to overcome the problems of low stigma exposure rate, low seed setting rate and low yield of rice sterile lines, and provide

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] The present embodiment 1 medicine comprises the following components by weight percentage:

[0026] Borax 6%,

[0027] Sodium nitrophenolate 0.6%,

[0028] Diethylhexanoate 1.0%,

[0029] 6-Benzylaminopurine 2.0%,

[0030] Brassinolide 0.0018%,

[0031] water 30%,

[0032] Diethylenetriamine 12%,

[0033] Fulvic Acid 46%,

[0034] Ethanol (acetone can also be used) balance.

[0035] The preparation method of the medicine of the present embodiment 1 is: proportioning ingredients. Add borax and diethylenetriamine to 15% water and heat to 100°C in a reactor to cool down to obtain a borax solution. Add 6-benzylaminopurine and diethyl hexanoate into fulvic acid, heat in a reactor at 60°C and stir evenly to prepare a mixture. Add brassinolide to ethanol and dissolve to obtain brassinolide alcohol solution. Sodium nitrophenolate is dissolved in 15% water to obtain an aqueous solution of sodium nitrophenolate, and then the brassinolate alcohol solution is mixed with t...

Embodiment 2

[0037] The present embodiment 2 medicine comprises the following components by weight percentage:

[0038] Borax 5%,

[0039] Sodium nitrophenolate 0.4%,

[0040] Diethylhexanoate 0.6%,

[0041] Forchlorfenuron 0.2%,

[0042] Brassinolide 0.0009%,

[0043] water 35%,

[0044] Diethylenetriamine 15%,

[0045] Fulvic Acid 40%,

[0046] Ethanol balance.

[0047] The preparation method of the medicament in Example 2 is: proportioning ingredients. Add borax, diethylenetriamine, and 15% water into a reactor, heat to 100°C, and cool to obtain a borax solution. Add diethyl aminohexanoate and forchlorfenuron into the fulvic acid, heat in the reactor to 80°C and stir evenly to prepare a mixture. Brassinolate is added to ethanol to obtain a brassinolate alcohol solution, and sodium nitrophenolate is dissolved in 20% water to obtain an aqueous solution of sodium nitrophenolate, and then the alcohol solution of brassinolate is mixed with an aqueous solution of sodium nitrophenolat...

Embodiment 3

[0049] Present embodiment 3 medicine comprises following component by weight percentage:

[0050] Borax 15%,

[0051] Sodium nitrophenolate 0.4%,

[0052] Diethylhexanoate 0.6%,

[0053] 6-Benzylaminopurine 3.0%,

[0054] Brassinolide 0.002%,

[0055] water 35%,

[0056] Diethylenetriamine 20%,

[0057] Fulvic Acid 23%,

[0058] Ethanol (acetone can also be used) balance.

[0059] The preparation method of the medicine of the present embodiment 3 is: proportioning ingredients. Add borax and diethylenetriamine to 15% water and heat to 100°C in a reactor to cool down to obtain a borax solution. Add 6-benzylaminopurine and diethyl hexanoate into fulvic acid, heat in a reactor at 60°C and stir evenly to prepare a mixture. Add brassinolate into ethanol and dissolve to obtain a brassinolate alcohol solution, dissolve sodium nitrophenolate in 20% water to obtain an aqueous solution of sodium nitrophenolate, then mix the alcoholic brassinolate solution with an aqueous solutio...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention pertains to the agriculture technical field and relates to a drug for increasing stigma protrusion rate of rice sterile line. The weight percentage of drug ingredients contains 5-20 percent of sodium borate, 0.2-1.0 percent of sodiumnitro phenolate, 0.5-1.5 percent of diethyl aminoethyl hexanoate, 0.2-0.4 percent of phytokinin, 0.0004-0.003 of brassin, 20-40 percent of water, 10-25 percent of diethylene triamine and 20-50 percent of fulvic, with auxiliary agent accounting for the rest percentage, wherein, the phytokinin is 6-aminopurine or forchlorfenuron and the auxiliary agent is either ethanol or acetone. The invention has no public pollution and can increase the stigma protrusion rate of rice sterile line by over 21 percent and the yield of seed-preparation of rice by over 21 percent when in use. In addition, the invention also provides a preparation method of the drug for increasing stigma protrusion rate of rice sterile line.

Description

Technical field: [0001] The invention belongs to the field of agriculture, and in particular relates to a medicine for increasing the stigma exposure rate of rice sterile lines so as to increase the yield of hybrid rice seed production and a preparation method thereof. Background technique: [0002] The yield of hybrid rice seed production includes three factors: the number of ears per mu of sterile lines, the rate of seed setting, and the weight of thousand grains. For specific sterile line seed production, the number of ears per mu can be arranged at a reasonable level through reasonable row ratio and transplanting density, and the thousand-grain weight is affected by the genetic factors of the sterile line with little variation, and the adjustable effect is low. Therefore, it is a key technical link to improve the seed setting rate of the sterile line. The seed setting rate of the CMS line is closely related to its own characteristics (compatibility, stigma exposure rate...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A01N59/14A01N33/22A01N37/12A01N43/54A01N43/16A01P21/00
Inventor 严庆海姜心禄
Owner SAAS BIOTECH & NUCLEAR TECH RES INST
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap